Remembering Emil von Behring: from Tetanus Treatment to Antibody Cooperation with Phagocytes.
Remembering Emil von Behring: from Tetanus Treatment to Antibody Cooperation with Phagocytes.
复制标题
DOI：
10.1128/mbio.00117-17
复制
发表时间：
2017-02-28
期刊：
影响因子：
6.4
通讯作者：
Kaufmann SH
中科院分区：
文献类型：
--
作者：
Kaufmann SH
世纪前，埃米尔·冯·贝林去世了。1901年，他是第一个获得诺贝尔医学奖的人，因为他成功地治疗了白喉和破伤风，他从板凳上发展到了床上。他还为免疫学的基础做出了贡献，因为他的疗法是基于用特异性抗血清进行被动免疫。作为一个雄心勃勃的人物，他并不回避与同事保罗埃利希和埃利亚斯梅奇尼科夫以及他的导师罗伯特科赫的摩擦。贝林不仅是一位出色的翻译研究者，也是一位成功的企业家和公私合作伙伴关系的早期支持者。
A century ago, Emil von Behring passed away. He was the first to be honored by the Nobel Prize for Medicine in 1901 for the successful therapy of diphtheria and tetanus, which he had developed from the bench to the bed. He also contributed to the foundation of immunology, since his therapy was based on passive immunization with specific antisera. Being an ambitious character, he did not shy away from friction with his colleagues Paul Ehrlich and Elias Metchnikoff and his mentor, Robert Koch. Behring was not only an excellent translational researcher but also a successful entrepreneur and early proponent of public-private partnerships.